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ABSTRACT 
Background: Tea has been shown to be a potent inhibitor of non- 
heme iron absorption, but it remains unclear whether the timing of 
tea consumption relative to a meal influences iron bioavailability. 
Objective: The aim of the study was to investigate the effect of a 
1-h time interval of tea consumption on nonheme iron absorption in 
an iron-containing meal in a cohort of iron-replete, nonanemic fe- 
male subjects with the use of a stable isotope (57Fe). 
Design: Twelve women (mean 6 SD age: 24.8 6 6.9 y) were 
administered a standardized porridge meal extrinsically labeled 
with 4 mg 57Fe as FeSO4 on 3 separate occasions, with a 14-d time 
interval between each test meal (TM). The TM was administered 
with water (TM-1), with tea administered simultaneously (TM-2), 
and with tea administered 1 h postmeal (TM-3). Fasted venous 
blood samples were collected for iron isotopic analysis and mea- 
surement of iron status biomarkers. Fractional iron absorption was 
estimated by the erythrocyte iron incorporation method. 
Results: Iron absorption was 5.7% 6 8.5% (TM-1), 3.6% 6 4.2% 
(TM-2), and 5.7% 6 5.4% (TM-3). Mean fractional iron absorption 
was found to be significantly higher (2.2%) when tea was adminis- 
tered 1 h postmeal (TM-3) than when tea was administered simul- 
taneously with the meal (TM-2) (P = 0.046). An w50% reduction 
in the inhibitory effect of tea (relative to water) was observed, from 
37.2% (TM-2) to 18.1% (TM-3). 
Conclusions: This study shows that tea consumed simultaneously 
with an iron-containing porridge meal leads to decreased nonheme 
iron absorption and that a 1-h time interval between a meal and tea 
consumption attenuates the inhibitory effect, resulting in increased 
nonheme iron absorption. These findings are not only important in 
relation to the management of iron deficiency but should also inform 
dietary advice, especially that given to those at risk of deficiency. This 
trial was registered  at clinicaltrials.gov as NCT02365103.  Am J  
Clin Nutr 2017;106:1413–21. 
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INTRODUCTION 
Iron deficiency is a condition defined as a lack of iron stores 
that leads to an enduring negative iron balance (1), which 
commonly affects women of childbearing age and children 
worldwide (2). Iron remains a marginal nutrient in the dietary 
intake of the UK population (3), leading to concerns of an in- 
creased risk of iron deficiency. The UK National Diet and Nu- 
trition Survey shows that women aged 19–64 y do not meet the 
recommended level of dietary iron intake, with a mean 6 SD 
daily intake of 9.6 6 3 mg, which equates to 78% of the Ref- 
erence Nutrient Intake (4). In countries where iron deficiency is 
not commonly attributable to iron metabolism–related diseases, 
it is suggested that insufficiency in absorbable iron to meet the 
iron requirement is one of the factors that may contribute to iron 
deficiency (5). The presence of inhibitors and enhancers in the 
diet will affect iron bioavailability more than the chemical forms 
of iron itself, and polyphenols have been shown to be potent 
inhibitors of iron absorption (6). Polyphenols can be found in 
plant-based sources, including tea, wine, and coffee (7). British 
adults (aged 19–64) consume an average of 1114 g tea, coffee, 
and water daily, and this amount is higher in women (1132 g/d) 
than in men (1097 g/d) on the basis of the recent National Diet 
and Nutrition Survey data (4). 
To the best of our knowledge, few human studies to date have 
investigated the inhibitory effect of tea consumption on iron 
absorption with the use of an isotope-labeled test meal (TM). 
Hurrell et al. (8) found that the inhibitory effect of black tea on 
 
Supported by the University of Chester; the UK Medical Research Council 
(grant U105960399) provided support with the iron isotopic analyses. 
Supplemental Tables 1 and 2 are available from the “Online Supporting 
Material” link in the online posting of the article and from the same link in 
the online table of contents at http://ajcn.nutrition.org. 
Present address for DK: Department of Veterinary Medicine, University of 
Cambridge, Cambridge, United Kingdom. 
Present address for SB: Department of Paediatrics, University of Cam- 
bridge, Cambridge, United Kingdom. 
Present address for DIAP: Department of Pathology, University of Cam- 
bridge, Cambridge, United Kingdom. 
Address correspondence to SM (e-mail: s.mushtaq@chester.ac.uk). 
Abbreviations used: CRP, C-reactive protein; ICP-MS/MS, inductively 
coupled plasma–tandem mass spectrometry; TM, test meal. 
Received May 25, 2017. Accepted for publication September 13, 2017. 
First published online October 18, 2017; doi: https://doi.org/10.3945/ajcn. 
117.161364. 
 
 
 
 
 
 AHMAD FUZI ET AL. 
iron absorption ranged between 79% and 94% in a study carried 
out by using a simple bread roll TM and different types of 
phenolic-containing beverages. Significant reductions in iron 
absorption were also observed (P , 0.001) when the TM was 
given with tea than when given with water in a study by 
Thankachan et al. (9), which used a rice-based TM. A study 
by Disler et al. (10) carried out in 10 male Sprague-Dawley 
rats reported that the minimum time interval for the inhibitory 
effect to be established was 30 min, with $1.8-fold higher iron 
absorption compared with no  time interval (27.6%–50.7%; 
P , 0.005). 
To date, it is apparent that limited data are available, especially 
from controlled intervention studies that investigated the in- 
hibitory effect on iron absorption of tea components, and no 
studies in humans that addressed iron absorption, particularly 
time interval, have been carried out in the United Kingdom. 
Because tea is not only widely consumed in the United Kingdom 
(11) but extensively consumed worldwide, the relevance of this 
study has global impact. Therefore, we aimed to assess the effect 
of the time interval of tea consumption relative to a meal on 
nonheme iron absorption from a typical Western breakfast with 
the use of a stable iron isotope (57Fe) in nonpregnant women and 
to assess the potential link between hepcidin concentration and 
iron absorption. 
 
 
METHODS 
 
Subjects 
Twelve premenopausal women aged 19–40 y were enrolled in 
the study with the use of posters and e-mails as recruitment 
media. All of the subjects were healthy, without any known 
history of gastrointestinal or metabolic disorders, nonpregnant, 
and nonlactating. The subjects were excluded if they had do- 
nated blood in the past 6 mo and regularly consumed nutritional 
supplements. Subjects were provided with a participant in- 
formation sheet and were briefed on the study protocol before 
providing written consent prior to partaking in the study. 
The sample size was estimated by using iron absorption data 
from a study by Derman et al. (12) carried out in Indian women 
aged between 21 and 71 y with the use of a maize meal labeled 
with radioisotope 55Fe or 59Fe. The study reported mean 6 SD 
iron absorption of 6.7% 6 6.2% when the TMs were adminis- 
tered with tea and 34.0% 6 23.0% when the TMs were ad- 
ministered without tea. With a Cohen’s effect size (d) of 1.32, 
the total sample size required in the present study was estimated 
to be 10 subjects (power = 0.95, a error probability = 0.05). 
Incorporating a potential 20% drop out rate, the total sample size 
required to show a significant difference in iron absorption be- 
tween the consumption of a meal with and without tea was es- 
timated to be 12. The sample size was estimated by using 
G*Power  software,  version  3.1.7  (Heinrich-Heine-Universita¨t 
Du¨sseldorf) (13). 
 
Study design 
A nonrandomized, controlled intervention study was carried 
out between November 2014 and March 2015 to investigate the 
effect of tea consumption on nonheme iron absorption with the 
use of 57Fe as a stable isotope (clinicaltrials.gov registration: 
NCT02365103). Each subject attended the clinic on 5 separate 
occasions over a period of 56 d during which they were ad- 
ministered 3 standardized TMs and a reference iron dose in the 
following order: 1) a TM administered with water [TM-1 (con- 
trol)], 2) a TM administered simultaneously with tea (TM-2), 3)a 
TM administered with tea 1 h postmeal (TM-3), and 4) a refer- 
ence iron dose without a TM. The study protocol was approved by 
the National Research Ethics Service Committee North West– 
Greater Manchester East, United Kingdom (Research Ethics 
Committee reference: 14/NW/0310; Integrated Research Applica- 
tion System project 154775). All of the procedures were car- 
ried out in accordance with the Helsinki Declaration of 1975 as 
revised in 1983. 
 
Study protocol 
Eligible volunteers provided informed consent at the begin- 
ning of the study. All of the subjects were required to fast for 
w10 h the night before each test dose of iron. The scheduled 
clinic visits at the clinical research laboratories in the De- 
partment of Clinical Sciences and Nutrition, University of 
Chester, were between 0800 and 1000. All of the subjects were 
asked to attend a total of 5 clinic sessions (days 0, 14, 28, 42, 
and 56), with a 14-d interval between clinic visits to allow the 
incorporation of the isotope into the erythrocytes. A standard- 
ized TM of porridge, extrinsically labeled with 57FeSO4, was 
administered to the subjects with water or tea depending on the 
clinic, under supervision of the investigator. The subjects were 
not permitted to consume food or beverages for 3–4 h after the 
administration of the TM. All of the containers used to admin- 
ister the TMs were washed with ultrapure water to ensure 
complete consumption of both TMs and the isotope label. The 
study protocol is summarized in Figure 1, and details of each 
clinic session are described in the following sections. 
 
Clinic visit 1 (day 0) 
Subjects’ height and weight were measured, and a 30-mL 
fasted blood sample was collected in trace element–free EDTA 
blood collection tubes for isotopic analysis and iron status 
measurements. The whole-blood sample collected at each clinic 
was used for iron isotopic analysis, and the plasma sample was 
used for iron status measurements. The investigator conducted a 
24-h food recall interview, and subjects were given a 3-d food 
diary to record their dietary intake at home. Subjects were then 
administered TM-1 (with water) to serve as a control. 
 
Clinic visit 2 (day 14) 
Subjects’ weight was measured, and a 30-mL fasted blood 
sample was collected in trace element–free EDTA blood col- 
lection tubes. The investigator conducted a 24-h food recall 
interview, and subjects were then administered TM-2 (with tea). 
 
Clinic visit 3 (day 28) 
The third clinic visit followed the same procedures as in clinic 
visit 2, but subjects were administered TM-3 (with tea 1 h 
postmeal). 
 
Clinic visit 4 (day 42) 
The fourth clinic visit followed the same procedures as in 
clinic visit 2, but subjects were administered a reference iron dose 
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FIGURE 1 Flowchart of study protocol (5 clinic visits with 14-d intervals). 
 
(3 mg 57Fe as FeSO4 and 35 mg ascorbic acid) without ad- 
ministration of any TM and were given a further 3-d food diary 
to record their dietary intakes. 
 
Clinic visit 5 (day 56) 
Clinic visit 5 followed the same procedures as in clinic visit 2, 
with the collection of a final whole-blood sample without the 
administration of a TM. 
 
 
Stable isotope labels 
A single isotope technique was used in the present study with 
the use of a stable iron isotope (57Fe, 95.93% enriched; Trace 
Sciences) in metal form (300 mg), which was converted into 
ferrous sulfate solution (57FeSO4), sterilized, and tested for 
endotoxin (Anazao Health Corporation) and declared safe for 
human consumption. The enriched stable iron isotopes were 
transferred and kept in individual vials, flushed with nitrogen 
before  being  sealed,  and  stored  at  2208C  until  TM  adminis- 
tration. The specified dosages for TMs and the reference iron 
dose used in the study were 4 and 3 mg, respectively. The ref- 
erence iron dose of 3 mg 57Fe with 35 mg ascorbic acid ad- 
ministered during a fasted condition was used as a measure of 
iron absorption under optimal state (14). 
The dissolution process to produce a clear 57FeSO4 solution, 
which was added extrinsically to the TMs, was carried out by 
the Anazao Health Corporation on the basis of the company’s 
standard procedure. After complete dissolution of the elemental 
57Fe with sulfuric acid, which resulted in a clear and colorless 
solution, the solution was filtered over a 0.5-mm membrane. The 
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prepared 57FeSO4 solution was shipped to the clinical research 
laboratory at the University of Chester in 1 vial containing a 
75-mL solution, which was then transferred into individual sterile, 
borosilicate, glass, clear sample vials with fitted caps (Fisher 
Scientific UK Ltd.), labeled with dosage and concentration. The 
labeled vials were flushed with nitrogen gas, sealed, and stored at 
2208C  until  the  day  of  TM  administration.  A  total  volume  of 
75 mL 57FeSO4 provides 4 mg 
57Fe/mL. 
 
TMs 
TM preparation and composition 
The TM meal used in the present study consisted of instant oat 
porridge (Sainsbury’s UK Ltd.). TMs were freshly prepared on 
the day of each clinic by adding 200 mL boiling ultrapure water 
(TraceSELECT Ultra, Fluka Analytic; Sigma-Aldrich UK Ltd.) 
to 55 g porridge. This TM was used at all clinics and was pre- 
pared according to the same standardized method. The nutri- 
tional content of the porridge is summarized in Table 1. To each 
TM, a 4-mg dose of extrinsically labeled 57Fe was added before 
consumption. The reference iron dose was extrinsically labeled 
with a 3-mg dose of 57Fe with 35 mg ascorbic acid and ad- 
ministered in ultrapure water without any TMs (clinic visit 5). 
 
Preparation of tea 
Black tea (Yorkshire Tea; Bettys and Taylors Group Ltd.) was 
prepared with the use of a standardized method at each clinic, by 
adding 200 mL boiling ultrapure water (TraceSELECT Ultra, 
Fluka Analytic) to 1 tea bag (3 g), and the mixture was steeped 
and infused for 3 min before straining for consumption. In each 
cup of tea, 12 mL homogenized semi-skim milk (Lakeland 
Dairies Co-op Society UK Ltd.) was added, and subjects were 
offered white granulated sugar (Fairtrade International) with the 
tea according to their preference. The tea was prepared on the day 
of the clinic and kept warm in a flask before consumption. The tea 
was administered at specific times either simultaneously with the 
porridge meal or 1 h postmeal. 
 
Anthropometric measurements 
Both height (centimeters) and weight (kilograms) were 
measured by using electronic scales (model 875; Seca) and a 
wall-mounted digital stadiometer (model 264; Seca) at baseline 
 
TABLE 1 
Nutritional composition of porridge test meals 
 
Nutrient Value per serving1 
Energy, MJ 8.63 
Total fat, g 3.4 
SFAs, g 0.6 
MUFAs, g 1.3 
PUFAs, g 1.3 
Carbohydrate, g 32.8 
Sugars, g 8.7 
Starch, g 24.0 
Fiber, g 3.9 
Protein, g 8.7 
Salt, g 0.14 
1 One serving = 55 g. 
before any of the TMs were administered. The instruments used 
were calibrated before every measurement. BMI was then cal- 
culated by using the equation BMI = weight (kg)/height (m2) and 
categorized by using cutoff values from the WHO (15). 
 
Blood sample handling 
Both whole blood and plasma obtained from venipuncture 
were used in the study for analysis. At each clinic, 30-mL venous 
blood samples were collected with the use of trace element–free 
blood collection tubes containing EDTA. A total of 6 mL whole 
blood was placed into micro-centrifuge tubes and stored at 
2808C  before  isotopic  iron  analyses  and  was  also  used  to 
measure full blood count indexes on the day of each clinic. The 
remaining blood samples were centrifuged at 1600 3 g at 48C 
for 10 min by using a benchtop centrifuge to obtain plasma 
samples, which were placed into micro-centrifuge tubes and 
stored at 2808C until analyses of iron status biomarkers. Whole- 
blood and plasma samples were used for the analysis of iron 
status biomarkers, including full blood counts (red blood cells, 
hemoglobin concentration, hematocrit percentage, mean cor- 
puscular volume, mean corpuscular hemoglobin, and mean 
corpuscular hemoglobin concentration), plasma ferritin, plasma 
C-reactive protein (CRP), and plasma hepcidin concentrations. 
 
Measurement of iron status biomarkers 
Whole-blood samples were used to measure full blood count 
indexes by using an automated Ac.T diff Hematology Analyzer 
(Beckman Coulter Inc.). Plasma samples were used for the 
analysis of ferritin concentrations with an automated immu- 
noanalyzer Mini VIDAS (Biomeriuex), CRP concentrations were 
measured by using commercially available human ELISA kits 
(Quantikine Human CRP Immunoassay ELISA kit; R&D Sys- 
tems Inc.), and hepcidin concentrations were measured by using a 
commercially available human ELISA kit (Human Hepcidin 
ELISA kit; Sincere Biotech Co. Ltd.). 
 
Isotopic analysis of blood samples 
Isotope ratio measurements were carried out by using an 
Agilent 8800 triple quadrupole inductively coupled plasma– 
tandem mass spectrometry (ICP-MS/MS) instrument (ICP-QQQ; 
Agilent Technologies). Samples and standards were introduced 
into the ICP-MS/MS with a MicroMist nebulizer and a Peltier- 
cooled (28C) Scott-type spray chamber. The Agilent 8800 con- 
tains an octopole-based collision-reaction cell, which is located 
between 2 quadrupole analyzers. A mixture of 10% ammonia in 
helium was introduced into the octopole cell as a reaction gas to 
remove the interferences on iron isotopes (Supplemental Table 
1) and to attenuate the signal at the appropriate level for precise 
isotope ratio analysis. Iron isotopes were measured as iron- 
ammonia clusters [mFe (NH3)2] at masses of 88, 90, 91, and 
92. Mass bias correction was performed by external standard 
correction with the use of iron (Fe). Pure Single-Element 
Standard (1000 mg/mL, 2% HNO3; Perkin Elmer) was used    
as a baseline reference. Frozen whole-blood samples were al- 
lowed to reach room temperature and then vortex mixed. One 
hundred microliters of the sample was mixed with 9.9 mL 
0.005% tetramethylammonium hydroxide (vol:vol; BioXtra 
grade; Sigma-Aldrich). 
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Estimation of fractional iron absorption 
Fractional iron absorption (percentage) was estimated by the 
erythrocyte iron incorporation method, 14 d postdosing of the 
isotope, which involved the use of published equations to es- 
tablish the percentage of iron absorption in each subject. Blood 
volume was used to calculate the circulating iron body pool (16) 
by using a published equation specific for females (17). On the 
basis of the estimation of blood volume and circulating body iron 
pool for each subject, iron incorporation into red blood cells was 
calculated by using another equation, which assumed that 80% 
of the absorbed iron was incorporated into erythrocytes (18, 19). 
The final fractional iron absorption was derived from mole 
fraction calculations for each iron source (“endogenous” iron and 
iron from the labeled oral dose) in the blood samples. This re- 
quired knowledge (from ICP-MS/MS measurements) of the 
abundance of each iron isotope (56Fe, 57Fe, 58Fe) in the previous 
and present blood samples and the abundance of the iron iso- 
topes in the oral isotope dosage (mainly 57Fe). The erythrocytes 
became progressively more enriched with 57Fe as the subjects 
consumed more TMs because iron is not lost from erythrocytes 
until  they  break  down  after  w120  d.  This  extra enrichment 
(above natural abundance) was taken into account when frac- 
tional iron absorption was estimated after each TM by using the 
previous blood sample’s iron isotope abundances as the “endog- 
enous” value. The calculated fractional iron absorption (percent- 
age) was then normalized to a fixed reference value of 40% by 
using the reference iron dose (14) to take into account intersubject 
variability (20). 
 
Assessment of dietary intake 
Two dietary assessment methods were used in the present 
study. Subjects were required to complete a 3-d food diary within 
the week after the baseline clinic visit and within the week before 
the postintervention clinic  visit  (to  include  2  weekdays  and 
1 weekend day) to estimate their habitual dietary intake. To 
ensure that subjects had not consumed unusually high amounts of 
iron-rich foods immediately before each clinic visit, a 24-h recall 
interview was completed at each visit to assess dietary intake 1 d 
before the TM administration, during which subjects were asked 
to recall food consumption, including beverage consumption for 
the past 24 h in detail to the investigator. All of the dietary records 
were analyzed for nutritional content by using computerized 
dietary analysis software (Microdiet for Windows software, 
to be reported as means 6 SDs in Results. One-factor repeated- 
measures ANOVAs were performed to compare the iron ab- 
sorption from each pair of meals in comparison to the control 
TM (water). Pearson’s correlation coefficient tests were per- 
formed to investigate the association between different iron 
status biomarkers and iron absorption (fractional absorption and 
total absorbed in milligrams). Differences were considered sig- 
nificant with a P value #0.05. 
 
 
RESULTS 
 
Baseline physical characteristics, iron status, and dietary 
intake of subjects 
All 12 women who commenced the study completed all phases 
of study, with no reports of adverse events. The subjects were 
healthy women with a mean 6 SD age of 24.8 6 6.9 y and a 
BMI (in kg/m2) of 22.6 6 2.7, which is in the normal range 
(Table 2). At baseline, all of the subjects had plasma ferritin 
concentrations within the normal range for healthy women and 
no elevated plasma ferritin concentration due to acute-phase 
reactions, indicated by the normal plasma CRP concentrations. 
Seven of the 12 subjects were not iron deficient on the basis of 
plasma  ferritin  concentrations  .15  mg/L,  and  only  2  subjects 
were anemic (hemoglobin concentrations of 9.0 and 10.0 g/dL) 
at baseline. The mean 6 SD plasma hepcidin concentration was 
96.0 6 119.6 ng/mL, which was within the expected normal 
range, with the exception of 3 subjects who had plasma hepcidin 
concentrations .150 ng/mL, which accounts for the large SD. 
There are no universal threshold values for normal hepcidin 
concentration; therefore, a reference value of between 17 and 
286 ng/mL from a study that reported the 5–95% normal range 
for healthy women, who were sampled in the United States and 
Italy (23), was used to compare the concentrations found in the 
present study. 
After dietary analysis of the food diaries, the estimated mean 6 SD 
daily energy intake was 6.75 6 1.91 MJ, which is consistent 
 
TABLE 2 
Baseline subject characteristics, iron status, and nutritional intakes1 
Variable Mean 6 SD 
Age, y 24.8 6 6.9 
Physical characteristics 
 
 
 
reference values from the 1991 Committee on the Medical As- 
pects of Food Policy were used for comparison with intakes of 
energy, macronutrients, and micronutrients of the subjects (22). 
 
Statistical analysis 
All of the statistical analyses were performed with IBM SPSS 
Statistic Data Editor Software (version 21). The Shapiro-Wilks 
test was used to ascertain the normal or non-normal distribu- 
tion for each variable. The non-normally distributed data, in- 
cluding the fractional iron absorption (percentage) and total iron 
absorbed (milligrams) were log-transformed for the purpose of 
performing statistical analyses, and results were re-transformed 
 
 
 
Iron status biomarkers 
Hemoglobin, g/dL 12.33 6 1.52 
Hematocrit, % 35.97 6 4.49 
RBCs, 31012/L 3.93 6 0.55 
Mean cell volume, fL 91.84 6 6.93 
Plasma ferritin, mg/L 38.8 6 42.7 
Plasma CRP, mg/L 0.62 6 0.77 
Plasma hepcidin, ng/mL 96.0 6 19.6 
Mean daily nutritional intake 
Energy, MJ 6.75 6 1.91 
Protein, g 66.1 6 23 
Iron, mg 6.7 6 1.5 
Tea intake/d, cups 2 (average infusion) 
1 n = 12. CRP, C-reactive protein; RBC, red blood cell. 
version 2.8.8; Downlee Systems UK Ltd.). The food items used Height, m 166.6 6 6.5 
for the analysis were derived from McCance and Widdowson’s Weight, kg 63.0 6 10.8 
The Composition of Foods, 6th summary edition (21). Dietary BMI, kg/m2 22.6 6 2.7 
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with the UK population data of 6.78 6 1.9 MJ for women aged 
between 19 and 64 y (4). Mean 6 SD daily iron intake was 
6.7 6 1.5 mg, nearly 50% of the Reference Nutrient Intake, and 
was lower than in the UK population for women aged 19–64 y 
(9.6 6 3.0 mg/d). Habitual iron intake (based on the 3-d food 
diary), however, was found to be higher (8.4 6 1.8 mg) at day 
56 than at baseline (6.7 6 1.5 mg) (P = 0.035). Mean 6 SD 
daily iron intake estimated from the 24-h recall was 9.7 6 5.5 mg, 
and the dietary analysis from each clinic showed no unusually high 
intakes of iron, calcium, or vitamin C, which may have con- 
founded subjects’ iron absorption. 
There were also no changes observed in subjects’ hemoglobin 
and plasma hepcidin concentrations between baseline and 
postintervention, except for plasma ferritin, which was signifi- 
cantly lower postintervention (29.4 6 33.4 mg/L) than at base- 
line (38.8 6 42.7 mg/L) (P = 0.026). Despite the lower plasma 
ferritin concentration postintervention, it was within the range of 
replete  iron  stores  (.15  mg/L).  The  absorption  observed  from 
the reference iron dose of 25.4% suggests that absorption was 
not affected by the changes observed in subjects’ iron stores. 
 
 
Iron absorption from TMs 
The present study used 3 standardized TMs administered 
successively at 14-d intervals either with water (TM-1), simul- 
taneously with tea (TM-2), or with tea administered 1 h after the 
test meal (TM-3). None of the TMs contained nonheme iron and 
each was labeled extrinsically with 4 mg 57Fe as FeSO4, except 
for the reference iron dose, which was labeled with 3 mg 57Fe as 
57FeSO4 and 35 mg ascorbic acid (to enhance the iron absorp- 
tion of the reference dose). TM-1 served as the reference meal 
and was used as the basis for comparison and to calculate iron 
absorption ratio and tea inhibitory effect. Absorption data for the 
reference iron dose were used to correct the intervariability 
between subjects’ iron status background, normalized to a fixed 
reference value of 40% (24) on the basis of a published equation 
(20). Table 3 shows the iron absorption (percentage), iron ab- 
sorption ratio to the control TM (water), and total iron absorbed 
(milligrams). Each mean value for iron absorption comprised 12 
values, 1 for each subject. For TM-1, 3 of the subjects had ab- 
sorption values of “0%” because their enriched isotope ratios 
(57Fe:58Fe) were below the limit of quantification in compari- 
son to the unenriched sample. In other words, the instrument 
(ICP-MS/MS) was unable to confidently distinguish a “signal” 
from the background “noise” in these samples. This was also the 
case for 3 subjects at TM-2 and 2 subjects at TM-3. 
The mean iron absorption (percentage) was higher in TM-1 
(meal + water) and in TM-3 (meal + tea + 1 h) than in TM-2 
(meal + tea) (data shown in Table 3), as anticipated. A reduction 
of w35% in fractional iron absorption was observed when the 
TM was administered simultaneously with tea (TM-2) compared 
with the TM administered with water (TM-1), but this difference 
was not significant (P = 0.398). The mean fractional iron ab- 
sorption was w2.2% higher, in absolute terms, when tea was 
administered 1 h after the subjects were administered their TM 
(TM-3) (P = 0.046) than when the TM was administered si- 
multaneously with tea (TM-2). This was similar to the fractional 
iron absorption of the meal administered only with water (5.73% 
compared with 5.69%). Consistent with the percentage of iron 
absorbed, the mean total iron absorbed (milligrams) was also 
significantly higher by 0.05 mg in TM-3 (meal + tea + 1 h) 
compared with TM-2 (meal + tea) (P = 0.049). There was no 
significant difference between TM-1 (meal + water) and TM-2 
(meal + tea) with regard to the total iron absorbed (P = 0.530). 
There were substantial variations in fractional iron absorption 
between subjects. There was a wide range of percentages of 
absorption, varying from undetectable to 31.1% (Supplemental 
Table 2). However, the fractional iron absorption reported in the 
present study was normalized by using a reference iron dose to 
account for intervariability between subjects, which enabled the 
findings  to be  compared against  the previously published liter- 
ature. The inhibitory effect was reduced by w50%, from 37.2% 
in TM-2 (meal + tea) to 18.1% in TM-3 (meal + tea + 1 h), in- 
dicating that allowing a 1-h time interval between a meal and tea 
consumption will lead to increased iron absorption. 
No significant association was observed between both of the 
principal iron status biomarkers (plasma ferritin and plasma 
ferritin concentrations) and iron absorption. However, positive 
associations were observed between plasma ferritin and plasma 
hepcidin concentrations when the TM was administered 1) with 
water (r = 0.918, P = 0.0001) (Figure 2A), 2) simultaneously 
with tea (r = 0.882, P = 0.0001) (Figure 2B), and 3) with tea 1 h 
postmeal (r = 0.841, P = 0.001) (Figure 2C), which indicates a 
very strong association between these 2 key iron biomarkers that 
play a substantial role in the regulation of iron absorption. 
 
 
DISCUSSION 
The study investigated the effect of tea consumption on 
nonheme iron absorption from a porridge meal that used a 57Fe 
iron isotope, as well as ascertaining the impact of time inter-  
val of the potential inhibitory effect of consuming tea relative  
to consumption of an iron isotope–labeled porridge meal. In 
agreement with previous studies (8, 9, 12, 25–29), the present 
study shows that tea reduces nonheme iron absorption by $37% 
when compared with water used as a control beverage. The 
 
TABLE 3 
Fractional iron absorption from TMs with specified beverages and iron absorption ratio (tea administration relative 
to water)1 
 TM-1 (administered 
with water) 
TM-2 (administered with 
tea simultaneously) 
TM-3 (tea administered 
1 h postmeal) 
Fractional iron absorption, % 5.7 6 8.5 3.6 6 4.2 5.7 6 5.4* 
Iron absorption ratio 1 0.65 6 0.67 1.18 6 1.19 
Total iron absorbed, mg 0.23 6 0.51 0.14 6 0.26 0.19 6 0.28y 
1 Values are means 6 SDs. A 1-factor repeated-measures ANOVA was performed to assess the differences in mean 
iron absorption between each test meal. *,yDifferent from TM-2: *P = 0.046, yP = 0.049. TM, test meal. 
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consistent with findings from previous studies that used a cereal- 
based TM in their study (26, 27). These studies reported a wide 
range of fractional iron absorption values, between 0.56% and 
18.8% (31, 32). 
Consistent with findings reported from previous studies, de- 
spite the difference in TM used, iron absorption was reduced 
when the tea was administered with a TM as opposed to when 
administered with water. Table 4 compares iron absorption re- 
ported in previous studies in which TMs were administered with 
either water (as a control) or tea to show the inhibitory effect. 
The magnitude of the inhibitory effect shown in previous studies 
ranged  between  26%  and  99%  in  comparison  to  the present 
study,  which  was  w37%.  Variability  in  tea  brewing time, 
brands, and the total amount of tea used, which may influence 
the phenolic concentration, are probably among the factors that 
contribute to discrepancies in the findings (33). The iron status 
of the subjects may also dictate iron absorption and this has been 
shown in previous studies. A potential explanation for the lower 
inhibitory effect of tea observed in the present study could be 
due to the majority of the subjects not being anemic or iron 
deficient. This is supported by the low mean 6 SD absorption of 
the reference iron dose (25.4% 6 18.3%) compared with pre- 
vious studies that reported a higher absorption of iron from both 
TMs and reference doses (Table 4). Thankachan et al. (9) 
compared iron absorption from a rice meal between subjects 
with iron deficiency anemia and normal subjects and showed 
that iron absorption was higher in the iron deficiency anemia 
group (7.1%) than in the control group (3.5%), which suggests 
that iron status has a significant impact on the amount of iron 
absorption and is based on physiologic requirements. 
The finding that plasma ferritin and plasma hepcidin concen- 
trations were positively associated in the present study is consistent 
with a limited number of previous studies that measured iron 
absorption concurrently with hepcidin and ferritin concentrations, 
despite the different TMs used (34–36). Hepcidin, a systemic iron 
regulator, directly binds ferroportin to cause its internalization and 
degradation to hinder iron efflux (37). 
The inhibition of iron absorption by tea observed in this study 
could be due to the formation of insoluble iron-tannin complexes 
in the lumen of the gut (27). In support of the findings from 
previous studies that tea is a prominent inhibitor of iron ab- 
sorption, the present study showed that a 1-h time interval has a 
substantial effect in reducing the inhibitory effect by increasing 
FIGURE 2 Associations between log10 plasma ferritin and plasma hep- 
cidin concentrations on day 14 (A), day 28 (B), and day 42 (C). n = 12. 
 
 
study also shows that a 1-h time interval between tea con- 
sumption and a meal has a substantial impact in counteracting 
this inhibitory effect, by $1.6-fold. 
In the present study, the overall mean 6 SD iron absorption 
from porridge, administered with either water (TM-1) or tea 
(TM-2 and TM-3), was #6%. Depending on the conditions and 
chemical forms of iron itself (heme or nonheme), the fractional 
iron absorbed by individuals  is  reported  to  be  classically  
low, ranging from as low as 5% to as high as 35% (30). It can be 
presumed that the nature of the cereal-based meal is the main 
contributory factor that leads to the low iron absorption, because 
the TM used in the present study had a potentially low amount 
of iron with the presence of phytate as an iron inhibitor, which is 
the absorption  by $37%.  There  is limited evidence to   support 
this finding on the time interval effect, specifically in human 
studies, because previous studies were carried out in rats or used 
other polyphenol-containing beverages. Disler et al. (10) showed 
that the time interval between the administration of tea and an 
iron-containing meal substantially reduced the inhibitory effect. 
However, tea was administered at several time points #3  h 
before iron solutions were administered, instead of after the TM 
as in the present study. A linear relation between the time in- 
terval and iron absorption was observed, and the absorption was 
w2-fold higher if the tea was administered 1 h before a meal, 
which is similar to the 1.6-fold magnitude increase (TM-2 
compared with TM-3) observed in our study. 
It should be noted that the iron absorption amounts reported in 
the present study are relative to a specific meal. However, gas- 
tric emptying of solid foods can vary between individuals and 
can also be affected by variations in meal components and 
  
 
 AHMAD FUZI ET AL. 
TABLE 4 
Inhibitory effect of tea consumption on iron absorption in comparison to water as a control beverage1 
Absorption,3 % 
Study, country, 
year (ref) 
Population 
(n); age,2 y Test meals 
 
Meal (water) Meal (tea) 
 
Inhibition,4 % 
Reference 
iron dose,3 % 
Present study5 Healthy women 
(n = 12); 24.8 6 6.9 
Porridge + 200 mL tea 5.7 6 8.5 3.6 6 4.2 37 25.4 6 18.3 
Disler et al., India, 
1975 (25)6,7 
Healthy women 
(n = 8); 26–60 
Bread + 200 mL 
black tea 
Rice and soup  + 
200 mL black tea 
10.4 6 4.4 
 
10.8 6 4.1 
3.3 6 3.0 
 
2.5 6 1.6 
68 
 
77 
35.8 6 25.0 
 
34.7 6 24.7 
Derman et al., India, 
1977 (12)7 
Healthy women 
(n = 22); 21–71 
Maize porridge + 
150 mL black tea 
3.8 6 4.0 2.1 6 2.5 45 50.5 6 31.5 
de Alarcon et al., 
Italy, 1979 (26)7 
Thalassemia patients 
(n = 5); 11–23 
Hamburgers + 240 mL 
tea 
15.6 6 12.8 5.2 6 5.5 67 NA 
Morck et al., USA, 
1983 (27)7 
Healthy adults 
(n = 37); 18–50 
Beef hamburger + 
200 mL tea 
3.71 (2.94, 4.68) 1.32 (1.01, 1.71) 64 15.73 (13.22, 18.71) 
Kaltwasser et al., Hemochromatosis Homogenized rice and 22.1 6 3.4 6.9 6 1.4 69 NA 
Germany, 1998 
(28)7 
patients (n = 18); 
47.4 6 16.1 
beef + 200 mL tea     
Hurrell et al., USA, 
1999 (8)7 
Healthy adults 
(n = 77); 19–40 
Bread roll + 275 mL 
tea 
   NA 
  275 mL tea (n = 9) 12.9 (10.7, 15.6) 0.74 (0.57, 0.95) 94  
  275 mL tea (n = 10) 5.63 (4.64, 6.84) 0.89 (0.68, 1.16) 84  
  275 mL tea (n = 10) 4.46 (3.47, 5.72) 0.92 (0.72, 1.18) 79  
  275 mL tea (n = 10) 8.64 (6.00, 12.4) 0.83 (0.56, 1.23) 90  
  100% strength 6.58 (4.76, 9.10) 0.59 (0.45, 0.96) 91  
  (n = 9)     
  50% strength 4.33 (3.31, 5.67) 1.05 (0.72, 1.53) 84  
  25% strength — 0.66 (0.45, 0.96) 99  
  25% strength — 1.18 (0.84, 1.66) 73  
  (n = 9)     
  10% strength — 1.48 (0.99, 2.21) 66  
  5% strength — 1.47 (1.03, 2.12) 66  
Samman et al., Healthy women (n = 10); Pasta + bread + 4 mL 12.1 6 4.5 8.9 6 5.2 26 38.6 6 18.1 
Australia, 2001 
(29)7 
26 6 4 green tea extract     
Thankachan et al., 
India,  2008 (9)5 
IDA and healthy women 
(n = 20); 18–35; IDA 
Tomato rice + tea 
(different amounts) 
   NA 
 group; 22.6 6 3.5; and 150 mL tea 18.2 (12.6, 26.4) 7.1 (4.3, 11.7) 61  
 iron-replete group; 24.3 300 mL tea 19.7 (13.5, 29.0) 5.6 (3.1, 10.1) 72  
 6 2.9 150 mL tea 7.5 (4.0, 14.2) 3.5 (2.1, 5.9) 53  
  300 mL tea 5.2 (2.6, 10.8) 1.6 (0.7, 3.8) 69  
1 IDA, iron deficiency anemia; NA, not applicable; ref, reference. 
2 Values are means 6 SDs or ranges. 
3 Values are means 6 SDs or geometric means; ranges in parentheses. 
4 Inhibitory effect (%) =  [meal (water) – meal (tea)] 3 100.  
5 Meals were extrinsically labeled with stable iron isotopes.   
6 A second substudy used an intrinsically labeled meal. 
7 Meals were extrinsically labeled with iron radioisotopes. 
 
 
consistency (38), which has been reported to range between 45 
and 108 min in several studies in healthy subjects who consumed 
TMs of different compositions (39–41). 
In conclusion, the present study shows that tea can be dis- 
tinctly regarded as a potent inhibitor of nonheme iron ab- 
sorption from a cereal-based breakfast. It is also evident from 
this study that not consuming tea simultaneously with a meal 
will have an impact on attenuating the inhibitory effect of  
tea on iron absorption. In addition to attenuating the effect of 
inhibition of iron absorption, it is pertinent to incorporate 
dietary advice that would increase iron absorption, such as 
incorporating ascorbate-containing fruit juice to a meal to 
 
enhance iron absorption. The findings of the present study may 
have implications in the management of iron deficiency, especially 
in at-risk groups predisposed to iron deficiency. Translating the 
findings of the present study into dietary advice at a health care 
level would help maximize dietary iron absorption, because tea is 
not only widely consumed in the United Kingdom (11) but is 
extensively consumed worldwide. 
The authors’ responsibilities were as follows—SM: designed the research 
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